Hetero Peg L Aspartero Injection

Name: Hetero Peg L Aspartero Injection
Brand: BALAJI CHEMICAL STORES
Price: 15000.0 INR
Availability: InStock

Price 15000.0 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

Hetero Peg L Aspartero Injection Specification

Origin of Medicine
India

Indication
Acute Lymphoblastic Leukemia

Packaging Type
Vial with carton box packaging

Life Span
Refer to expiry date on packaging (commonly 18-24 months)

Dosage Form
Injection

Brand Name
Hetero PEG L-Aspartero

Salt Composition
Pegaspargase (PEG L-Asparaginase)

Pacakaging (Quantity Per Box)
1 Vial per box

Drug Type
Prescription, Antineoplastic

Ingredients
PEG L-Asparaginase

Physical Form
Injection

Function

Recommended For
Treatment of Acute Lymphoblastic Leukemia (ALL)

Dosage
As prescribed by physician, typically 3750 IU per 5 mL vial

Dosage Guidelines
For IM/IV administration only, under medical supervision

Suitable For
Adults and pediatric patients as recommended

Quantity
5 mL Single Use Vial

Storage Instructions
Store in a refrigerator (2C-8C). Do not freeze.

Route of Administration
Intramuscular (IM) or Intravenous (IV)

Language on Packaging
English and Hindi

Strength
750 IU per mL, 3750 IU/5 mL vial

Color of Vial Cap
Blue

Prescription Required
Yes

About Hetero Peg L Aspartero Injection

Hetero Peg L-Asparterto Injection is a long-acting chemotherapy agent used in the treatment of acute lymphoblastic leukemia (ALL). It delivers pegylated L-asparaginase, which depletes asparagine, inhibiting cancer cell growth. Its extended action enhances efficacy while reducing dosing frequency and hypersensitivity reactions.

Effective Leukemia Treatment

Hetero PEG L Aspartero is specifically indicated for the treatment of Acute Lymphoblastic Leukemia (ALL). Its active ingredient, PEG L-Asparaginase, reduces the level of asparagine, an amino acid vital for leukemia cells, thereby suppressing their growth. This makes it a crucial component of chemotherapy protocols for ALL.

Safe and Controlled Administration

Administered either intramuscularly or intravenously, Hetero PEG L Aspartero should only be given by qualified healthcare professionals. The clear guidelines on dosage and frequency ensure optimal effectiveness while minimizing side effects. Close medical supervision throughout the treatment process enhances patient safety.

Convenient Packaging and Storage Guidelines

Each 5 mL vial is securely packaged in a carton box for single use, maintaining strict hygiene and ease of handling. The blue-capped vial is clearly labeled in both English and Hindi. For best results and safety, store the vial in a refrigerator (2C-8C), and do not freeze the product.

FAQ's of Hetero Peg L Aspartero Injection:

Q: How should Hetero PEG L Aspartero Injection be administered?

A: Hetero PEG L Aspartero Injection is designed for intramuscular or intravenous administration only. It must be administered by a healthcare professional in a clinical setting, strictly following the doctor's prescribed dosage.

Q: What is the primary benefit of using this injection for Acute Lymphoblastic Leukemia?

A: The main benefit of Hetero PEG L Aspartero is its effectiveness in depleting asparagine, a critical amino acid for leukemia cells, thereby inhibiting their growth and aiding in the treatment of Acute Lymphoblastic Leukemia.

Q: When is the appropriate time to use Hetero PEG L Aspartero Injection?

A: This medication is used as part of an ALL chemotherapy protocol and should only be administered according to the timetable set by your oncologist or healthcare provider.

Q: Where should the injection be stored before use?

A: Store the vial in a refrigerator at temperatures between 2C and 8C. Do not freeze the product, and always check the expiry date before use.

Q: What is the process for using Hetero PEG L Aspartero Injection?

A: The process involves a qualified healthcare professional preparing and administering the single-use 5 mL vial by either the IM or IV route. The exact dosage and frequency depend on the patient's treatment protocol and physician's recommendations.

Q: Is a prescription required to obtain Hetero PEG L Aspartero Injection?

A: Yes, this medication is classified as a prescription-only drug and should only be used under medical supervision for the treatment of Acute Lymphoblastic Leukemia.

Tell us about your requirement